D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 94 Citations 30,499 261 World Ranking 4911 National Ranking 459

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Surgery

Richard Hubbard mainly focuses on Internal medicine, Surgery, Incidence, Cohort study and Risk factor. The various areas that Richard Hubbard examines in his Surgery study include Hip fracture, Osteoporosis and Cumulative incidence. His research in Incidence intersects with topics in Epidemiology and Idiopathic pulmonary fibrosis.

His studies deal with areas such as Intensive care medicine and Interstitial lung disease as well as Idiopathic pulmonary fibrosis. His studies in Cohort study integrate themes in fields like Clinical trial, Hazard ratio, Prospective cohort study, Pediatrics and Cohort. Richard Hubbard has researched Risk factor in several fields, including Respiratory disease, Anesthesia and Antidepressant, Serotonin reuptake inhibitor, Reuptake inhibitor.

His most cited work include:

  • American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias (3012 citations)
  • Risk of Myocardial Infarction and Stroke after Acute Infection or Vaccination (960 citations)
  • Vascular Factors and Risk of Dementia: Design of the Three-City Study and Baseline Characteristics of the Study Population (477 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Internal medicine, Surgery, Lung cancer, Odds ratio and Pediatrics. His study looks at the intersection of Internal medicine and topics like Oncology with Chemotherapy. His work carried out in the field of Surgery brings together such families of science as Adverse effect and Comorbidity.

Richard Hubbard interconnects Stage, Cancer, Performance status and Intensive care medicine in the investigation of issues within Lung cancer. His Odds ratio study combines topics from a wide range of disciplines, such as Case-control study, Immunology and Confidence interval. His biological study spans a wide range of topics, including Epidemiology, Incidence, Disease and Asthma.

He most often published in these fields:

  • Internal medicine (39.22%)
  • Surgery (24.51%)
  • Lung cancer (24.26%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (39.22%)
  • Lung cancer (24.26%)
  • Oncology (8.33%)

In recent papers he was focusing on the following fields of study:

Richard Hubbard mostly deals with Internal medicine, Lung cancer, Oncology, Idiopathic pulmonary fibrosis and Cohort. His Lung cancer study incorporates themes from Cancer, Performance status, Family medicine, Stage and Radiation therapy. His Performance status study results in a more complete grasp of Surgery.

His research in Idiopathic pulmonary fibrosis intersects with topics in Physical therapy and Case-control study, Pathology. The study incorporates disciplines such as COPD, Incidence, Cohort study and Asthma in addition to Cohort. His study in Incidence is interdisciplinary in nature, drawing from both Odds ratio, Diabetes mellitus, Type 2 diabetes and Proportional hazards model.

Between 2016 and 2021, his most popular works were:

  • Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study (102 citations)
  • An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study. (86 citations)
  • An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study. (86 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Disease

His primary areas of investigation include Internal medicine, Idiopathic pulmonary fibrosis, Pathology, Case-control study and Lung. His study in Bronchiectasis, Cohort, Performance status, Epidemiology and Hip fracture is carried out as part of his Internal medicine studies. His Idiopathic pulmonary fibrosis study combines topics in areas such as Clinical epidemiology, Physical therapy and Primary care database.

His Case-control study research incorporates themes from Odds ratio and Cohort study. His Odds ratio research is multidisciplinary, incorporating perspectives in Granulomatosis with polyangiitis and Confidence interval. As part of the same scientific family, Richard Hubbard usually focuses on Myocardial infarction, concentrating on Incidence and intersecting with Disease.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias

William D. Travis;Talmadge E. King;Eric D. Bateman;David A. Lynch.
American Journal of Respiratory and Critical Care Medicine (2002)

4192 Citations

Risk of Myocardial Infarction and Stroke after Acute Infection or Vaccination

Liam Smeeth;Sara L. Thomas;Andrew J. Hall;Richard Hubbard.
The New England Journal of Medicine (2004)

1326 Citations

Seroprevalence, correlates, and characteristics of undetected coeliac disease in England

J West;R F A Logan;P G Hill;A Lloyd.
Gut (2003)

658 Citations

Lung cancer and cryptogenic fibrosing alveolitis : A population-based cohort study

Richard Hubbard;Andrea Venn;Sarah Lewis;John Britton.
American Journal of Respiratory and Critical Care Medicine (2000)

656 Citations

Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK

J Gribbin;R B Hubbard;I Le Jeune;C J P Smith.
Thorax (2006)

631 Citations

Increased Risk of Myocardial Infarction and Stroke Following Exacerbation of COPD

Gavin C. Donaldson;John R. Hurst;Christopher J. Smith;Richard B. Hubbard.
Chest (2010)

569 Citations

Bullous pemphigoid and pemphigus vulgaris—incidence and mortality in the UK: population based cohort study

S M Langan;L Smeeth;R Hubbard;K M Fleming.
BMJ (2008)

557 Citations

Vascular Factors and Risk of Dementia: Design of the Three-City Study and Baseline Characteristics of the Study Population

Marilyn Antoniak;Maura Pugliatti;Richard Hubbard;John Britton.
Neuroepidemiology (2003)

517 Citations

Malignancy and mortality in people with coeliac disease: population based cohort study

Joe West;Richard F A Logan;Chris J Smith;Richard B Hubbard.
BMJ (2004)

470 Citations

Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care

Johanna R Feary;Laura C Rodrigues;Christopher J Smith;Richard B Hubbard.
Thorax (2010)

470 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Richard Hubbard

Christophe Tzourio

Christophe Tzourio

University of Bordeaux

Publications: 203

Jean-François Dartigues

Jean-François Dartigues

University of Bordeaux

Publications: 182

Athol U. Wells

Athol U. Wells

Imperial College London

Publications: 148

Toby M. Maher

Toby M. Maher

University of Southern California

Publications: 131

Jonas F. Ludvigsson

Jonas F. Ludvigsson

Karolinska Institute

Publications: 127

Kevin K. Brown

Kevin K. Brown

National Jewish Health

Publications: 107

Fernando J. Martinez

Fernando J. Martinez

Cornell University

Publications: 106

Claudine Berr

Claudine Berr

Inserm : Institut national de la santé et de la recherche médicale

Publications: 101

Karen Ritchie

Karen Ritchie

Inserm : Institut national de la santé et de la recherche médicale

Publications: 90

Thomas V. Colby

Thomas V. Colby

Mayo Clinic

Publications: 85

Ganesh Raghu

Ganesh Raghu

University of Washington

Publications: 82

Luca Richeldi

Luca Richeldi

Catholic University of the Sacred Heart

Publications: 82

Kevin R. Flaherty

Kevin R. Flaherty

University of Michigan–Ann Arbor

Publications: 81

Louise V. Wain

Louise V. Wain

University of Leicester

Publications: 80

Vincent Cottin

Vincent Cottin

Claude Bernard University Lyon 1

Publications: 73

Harold R. Collard

Harold R. Collard

University of California, San Francisco

Publications: 71

Trending Scientists

Erick Cantú-Paz

Erick Cantú-Paz

Amazon (United States)

Deqing Zhang

Deqing Zhang

Chinese Academy of Sciences

Bingqiang Cao

Bingqiang Cao

University of Jinan

Bingfu Lei

Bingfu Lei

South China Agricultural University

Petr Saha

Petr Saha

Tomas Bata University in Zlín

Min Song

Min Song

Central South University

Raija Laiho

Raija Laiho

Natural Resources Institute Finland

Donald A. Falk

Donald A. Falk

University of Arizona

Chris R. Stokes

Chris R. Stokes

Durham University

Irena Hajnsek

Irena Hajnsek

German Aerospace Center

Dick F. Stegeman

Dick F. Stegeman

Radboud University Nijmegen

Daniel Goleman

Daniel Goleman

Rutgers, The State University of New Jersey

Michiaki Mishima

Michiaki Mishima

Kyoto University

Suzan Lewis

Suzan Lewis

Middlesex University

Desmond K. Runyan

Desmond K. Runyan

University of Colorado Denver

Something went wrong. Please try again later.